A pioneering wearable treatment for heart failure could soon change how millions of patients around the world receive care. Researchers from the University of Glasgow have found that a small wearable mini-pump delivering medication under the skin allows many heart failure patients to leave hospital earlier and safely continue treatment at home.

The breakthrough comes from the landmark SUBCUT HF II clinical trial, presented at the European Society of Cardiology Heart Failure Congress 2026 in Barcelona and simultaneously published in the European Journal of Heart Failure.

The study showed that patients using the wearable device were discharged almost five days earlier than those receiving conventional hospital-based treatment.

The findings may be especially relevant for India, where cardiovascular disease remains the leading cause of death and overcrowded hospitals face rising numbers of heart failure admissions.

According to the World Health Organization (WHO), cardiovascular diseases account for nearly 28% of all deaths in India.

Experts believe home-based heart failure care could ease pressure on healthcare systems while improving patients' quality of life.

Source:Ndtv